| Patient-specific induced pluripotent stem-cell models for long-QT syndrome A Moretti, M Bellin, A Welling, CB Jung, JT Lam, L Bott-Flügel, T Dorn, ... New England Journal of Medicine 363 (15), 1397-1409, 2010 | 1436 | 2010 |
| Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents A Kastrati, J Mehilli, J Pache, C Kaiser, M Valgimigli, H Kelbæk, ... New England Journal of Medicine 356 (10), 1030-1039, 2007 | 1358 | 2007 |
| A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of … M Seyfarth, D Sibbing, I Bauer, G Fröhlich, L Bott-Flügel, R Byrne, ... Journal of the American College of Cardiology 52 (19), 1584-1588, 2008 | 1097 | 2008 |
| Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial A Kastrati, J Mehilli, J Dirschinger, F Dotzer, H Schühlen, FJ Neumann, ... Circulation 103 (23), 2816-2821, 2001 | 909 | 2001 |
| Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial A Kastrati, J Mehilli, FJ Neumann, F Dotzer, J ten Berg, H Bollwein, I Graf, ... Jama 295 (13), 1531-1538, 2006 | 813 | 2006 |
| Ticagrelor or prasugrel in patients with acute coronary syndromes S Schüpke, FJ Neumann, M Menichelli, K Mayer, I Bernlochner, J Wöhrle, ... New England Journal of Medicine, 2019 | 748 | 2019 |
| Evaluation of prolonged antithrombotic pretreatment (cooling-off strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial FJ Neumann, A Kastrati, G Pogatsa-Murray, J Mehilli, H Bollwein, ... Jama 290 (12), 1593-1599, 2003 | 650 | 2003 |
| 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction G Ndrepepa, K Tiroch, M Fusaro, D Keta, M Seyfarth, RA Byrne, J Pache, ... Journal of the American College of Cardiology 55 (21), 2383-2389, 2010 | 584 | 2010 |
| Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial D Zohlnhöfer, I Ott, J Mehilli, K Schömig, F Michalk, T Ibrahim, ... Jama 295 (9), 1003-1010, 2006 | 578 | 2006 |
| Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement I MÜLLER, M Seyfarth, S RÜDIGER, B Wolf, G POGATSA-MURRAY, ... Heart 85 (1), 92-93, 2001 | 573 | 2001 |
| Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point G Ndrepepa, PB Berger, J Mehilli, M Seyfarth, FJ Neumann, A Schömig, ... Journal of the American College of Cardiology 51 (7), 690-697, 2008 | 562 | 2008 |
| Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction A Kastrati, A Dibra, C Spaulding, GJ Laarman, M Menichelli, M Valgimigli, ... European heart journal 28 (22), 2706-2713, 2007 | 529 | 2007 |
| Effect of glycoprotein IIb/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial … FJ Neumann, A Kastrati, C Schmitt, R Blasini, M Hadamitzky, J Mehilli, ... Journal of the American College of Cardiology 35 (4), 915-921, 2000 | 475 | 2000 |
| Restenosis after coronary placement of various stent types A Kastrati, J Mehilli, J Dirschinger, J Pache, K Ulm, H Schühlen, ... The American journal of cardiology 87 (1), 34-39, 2001 | 461 | 2001 |
| ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting S Schulz-Schüpke, RA Byrne, JM Ten Berg, FJ Neumann, Y Han, ... European heart journal 36 (20), 1252-1263, 2015 | 400 | 2015 |
| Bivalirudin versus unfractionated heparin during percutaneous coronary intervention A Kastrati, FJ Neumann, J Mehilli, RA Byrne, R Iijima, HJ Büttner, ... New England Journal of Medicine 359 (7), 688-696, 2008 | 396 | 2008 |
| CLINICAL PERSPECTIVE J Mehilli, A Kastrati, S Schulz, S Früngel, SG Nekolla, W Moshage, ... Circulation 119 (14), 1933-1940, 2009 | 388* | 2009 |
| Abciximab and heparin versus bivalirudin for non–ST-elevation myocardial infarction A Kastrati, FJ Neumann, S Schulz, S Massberg, RA Byrne, M Ferenc, ... New England Journal of Medicine 365 (21), 1980-1989, 2011 | 384 | 2011 |
| Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial A Schömig, J Mehilli, D Antoniucci, G Ndrepepa, C Markwardt, F Di Pede, ... Jama 293 (23), 2865-2872, 2005 | 373 | 2005 |
| Dantrolene rescues arrhythmogenic RYR2 defect in a patient‐specific stem cell model of catecholaminergic polymorphic ventricular tachycardia CB Jung, A Moretti, MM y Schnitzler, L Iop, U Storch, M Bellin, T Dorn, ... EMBO molecular medicine 4 (3), 180-191, 2012 | 371 | 2012 |
Adnan KastratiDeutsches Herzzentrum MünchenVerified email at dhm.mhn.de
